A Phase 4 interventional study of Fentanyl and Acetaminophen in Oocyte Retrieval and Postoperative Pain, sponsored by Brigham and Women's Hospital. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-29.
Sponsored by Brigham and Women's Hospital · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 47 studies testing fentanyl in Pain, Postoperative — 5 open to participants now, 6 under way, none of them phase 3. Fentanyl · Pain, Postoperative.
Among the 47 studies testing fentanyl in Pain, Postoperative, this one is the 12th largest by enrollment, is one of 3 that started in 2011, is one of 22 in phase 4, and was the 18th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →5 of the 47 studies testing fentanyl in Pain, Postoperative are open now, in 3 countries. Recruiting first, the newest first:
Konya City Hospital · Sites in Turkey
Ages 18–65
Duke University · Sites in United States
Ages 3–17 · Healthy volunteers
Assiut University
Ages 20–50 · Healthy volunteers
Assiut University
Ages 18+
Al-Azhar University · Sites in Egypt
Ages 21–60
By country, each count listing its studies:
Fentanyl: first FDA approval 1968 (SUBLIMAZE PRESERVATIVE FREE), first EMA approval 2006. What it is approved for, and how studies give it, is on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 50 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
47 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 5 · Phase 3 5 · Phase 4 22
First in 2003; this study’s year is marked. 3 started in 2011.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 100 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 80 across the 47 interventional studies. Of the 35 that completed or were terminated, 4 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 47 have an industry lead sponsor. The 10 most frequent:
Brigham and Women's Hospital is the lead sponsor of 1,270 studies on the registry; 230 are open to participants now.
Of its 117 completed or terminated interventional studies of FDA-regulated products, 65 (56%) have results posted.
11 studies in Pain, Postoperative by Brigham and Women's Hospital: 3 open now, 4 under way, none of them phase 3. Of 3 finished, 2 (67%) have results posted.
Among the 11 studies in Pain, Postoperative by Brigham and Women's Hospital, this one is the only one that started in 2011, is one of 3 in phase 4, and was the 2nd registered.
Brigham and Women's Hospital’s Pain, Postoperative studies by the year they started, since 2008.
2 of the studies testing fentanyl in Pain, Postoperative that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07670052Assiut UniversityIntraperitoneal Ketamine Versus Fentanyl as Adjuvants to Bupivacaine in Laparoscopic Cholecystectomy | 2027-06-01 |
| NCT03105518Brigham and Women's HospitalPredictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction | 2027-06-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 47 studies testing fentanyl in Pain, Postoperative, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Brigham and Women's Hospital’s 11 in Pain, Postoperative:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The central objective of this study will be to evaluate the relationship between estrogen levels and the pain following oocyte retrieval in women undergoing in vitro fertilization.
Subject will undergo standard clinical protocols for the entire oocyte stimulation cycle and all assisted reproductive procedure decisions and algorithms will be decided entirely independent of this study.
The anesthetic and postoperative pain regimens will use the same agents and dose ranges used in clinical standard practice; however, the regimens will be standardized, so as to limit confounding variables. The study regimen for anesthesia will differ from the current, clinical standard by the mandated use of actual body weight (in current practice, actual, adjusted ideal, or ideal body weights are used), the use of fentanyl 1 mcg/kg IV (instead of 100 mcg for everyone), and the standardization of postoperative analgesia (noted below). The total amount of fentanyl, propofol, and postoperative drugs will be recorded.
Postoperative analgesia will be standardized based on the subject's self reported verbal analogue score (VAS) and the timing of the report. The agents and timing used below differ from the current clinical standard by assessing VAS and responding with a certain regimen.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg.
Drug: Fentanyl · Drug: Acetaminophen · Drug: Oxycodone
0.5, 1 mcg/kg
Also known as: Sublimaze
Single + Oxycodone
Also known as: Tylenol
With Acetaminophen
Also known as: Percocet
Amount of Discomfort
Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale). VAS scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort.
Time frame: PACU admission, 15, 30 and 60 min postprocedure, postoperative day 3
Amount of Discomfort Following Discharge Until Embryo Transfer
Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale) after immediate postoperative period (1 hrs) but prior to Embryo Transfer on 3rd postoperative day. Visual Analogue Scale (VAS) scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort. Patients will record the type, dose, and timing of pain medicines in a diary to be returned at Embryo Transfer.
Time frame: After 1 hrs but less than 3 days
| Milestone | Analgesia Options |
|---|---|
| Started | 100 |
| Completed | 100 |
| Not completed | 0 |
Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale). VAS scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort.
| units on a scale | Analgesia Options |
|---|---|
| Time 0; ≤10 Follicles | 1.53 ± 2.13 |
| Time 0; > 10 Follicles | 3.25 ± 2.9 |
| Time 15; ≤10 Follicles | 2.68 ± 2.19 |
| Time 15; >10 Follicles | 3.61 ± 1.98 |
| Time 30; ≤10 Follicles | 1.66 ± 1.40 |
| Time 30; >10 Follicles | 2.93 ± 1.43 |
| Time 60; ≤10 Follicles | 0.97 ± 1.16 |
| Time 60; >10 Follicles | 2.19 ± 1.55 |
| Time POD 3; ≤ 10 Follicles | 1.44 ± 1.15 |
| Time POD 3; > 10 Follicles | 1.64 ± 1.82 |
Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale) after immediate postoperative period (1 hrs) but prior to Embryo Transfer on 3rd postoperative day. Visual Analogue Scale (VAS) scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort. Patients will record the type, dose, and timing of pain medicines in a diary to be returned at Embryo Transfer.
| units on a scale | Analgesia Options |
|---|---|
| POD1; ≤10 Folli | 2.15 ± 1.72 |
| POD1; >10 Follicles | 3.21 ± 1.87 |
| POD2; ≤10 Folli | 1.28 ± 1.89 |
| POD2; >10 Folli | 2.50 ± 2.35 |
Collected over 3 days. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Analgesia Options | 0/100 (0%) | 0/100 (0%) | 0/100 (0%) |
| Age, Continuous(years) | Analgesia Options |
|---|---|
| Mean | 35.54 ± 4.61 |
| Sex: Female, Male(Participants) | Analgesia Options |
|---|---|
| Female | 100 |
| Male | 0 |
| Ethnicity (NIH/OMB)(Participants) | Analgesia Options |
|---|---|
| Hispanic or Latino | 5 |
| Not Hispanic or Latino | 95 |
| Unknown or Not Reported | 0 |
| Race (NIH/OMB)(Participants) | Analgesia Options |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 5 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 5 |
| White | 90 |
| More than one race | 0 |
| Unknown or Not Reported | 0 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Mar 2011 (actual). Primary completion is estimated for Jun 2027, 195 months after the start.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 195 months is above that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Fentanyl · Acetaminophen · Oxycodone
Brigham and Women's Hospital →